-
Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-alpha and -gamma.
J Infect Dis. 1992 Dec;166(6):1401-3
PMID: 1331251
-
RELATIONSHIP BETWEEN THE ENVELOPE AND THE INFECTIVITY OF HERPES SIMPLEX VIRUS.
Proc Soc Exp Biol Med. 1964 Mar;115:814-6
PMID: 14155835
-
A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1.
J Virol. 1991 Aug;65(8):4078-90
PMID: 1649316
-
The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice.
J Infect Dis. 1991 Dec;164(6):1091-7
PMID: 1659596
-
The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice.
J Hyg (Lond). 1978 Oct;81(2):267-77
PMID: 212476
-
Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon.
J Virol. 1990 May;64(5):2187-92
PMID: 2157880
-
Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture.
Science. 1990 Nov 30;250(4985):1262-6
PMID: 2173860
-
The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
J Immunol. 1986 May 1;136(9):3481-5
PMID: 2420892
-
Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells.
J Gen Virol. 1988 Jun;69 ( Pt 6):1167-77
PMID: 2455018
-
Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency.
J Virol. 1989 Feb;63(2):759-68
PMID: 2536101
-
Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
Proc Natl Acad Sci U S A. 1989 Jun;86(12):4736-40
PMID: 2543985
-
A herpes simplex virus type 1 mutant containing a deletion within immediate early gene 1 is latency-competent in mice.
J Gen Virol. 1989 Sep;70 ( Pt 9):2501-6
PMID: 2550578
-
A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells.
Virology. 1989 Nov;173(1):276-83
PMID: 2554573
-
Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant.
J Virol. 1988 Jan;62(1):196-205
PMID: 2824847
-
Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription.
Virology. 1988 May;164(1):201-10
PMID: 2834869
-
Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant.
Virology. 1988 Sep;166(1):41-51
PMID: 2842955
-
Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene.
Proc Natl Acad Sci U S A. 1985 Aug;82(16):5265-9
PMID: 2991915
-
Three trans-acting regulatory proteins of herpes simplex virus modulate immediate-early gene expression in a pathway involving positive and negative feedback regulation.
J Virol. 1985 Dec;56(3):723-33
PMID: 2999428
-
Identification and separation of the two subunits of the herpes simplex virus ribonucleotide reductase.
J Virol. 1986 Mar;57(3):1177-81
PMID: 3005618
-
Retrograde axonal transport of horseradish peroxidase from cornea to trigeminal ganglion.
Acta Neuropathol. 1977 Apr 29;38(1):49-52
PMID: 300978
-
Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110.
J Gen Virol. 1986 Dec;67 ( Pt 12):2571-85
PMID: 3025339
-
Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture.
J Virol. 1987 Mar;61(3):829-39
PMID: 3027408
-
Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation.
J Virol. 1987 Jul;61(7):2171-4
PMID: 3035217
-
Latent herpesvirus infections of neurons in guinea pigs and humans.
Yale J Biol Med. 1987 Mar-Apr;60(2):159-67
PMID: 3495074
-
Biochemical studies on the herpes simplex virus-specified deoxypyrimidine kinase activity.
J Gen Virol. 1974 Sep;24(3):481-92
PMID: 4372300
-
Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity.
EMBO J. 1984 Dec 20;3(13):3135-41
PMID: 6098466
-
Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of alpha (immediate early) viral polypeptides.
J Virol. 1983 May;46(2):498-512
PMID: 6302315
-
Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent.
Virology. 1983 Nov;131(1):171-9
PMID: 6316649
-
Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis.
J Virol. 1995 Nov;69(11):6779-86
PMID: 7474089
-
Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5- mutants of herpes simplex virus 1.
Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10516-20
PMID: 7479831
-
Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice.
J Immunol. 1995 Oct 15;155(8):3964-71
PMID: 7561104
-
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
Nat Med. 1995 Sep;1(9):938-43
PMID: 7585221
-
Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1.
J Virol. 1995 Aug;69(8):4898-905
PMID: 7609058
-
An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation.
J Virol. 1995 May;69(5):3033-41
PMID: 7707530
-
The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections.
J Virol. 1995 Feb;69(2):904-9
PMID: 7815559
-
Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 gamma 34.5 mutants in a mouse eye model.
J Gen Virol. 1995 Feb;76 ( Pt 2):321-32
PMID: 7844554
-
Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus.
J Virol. 1995 Mar;69(3):1389-99
PMID: 7853471
-
Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats.
J Neurooncol. 1994;19(2):137-47
PMID: 7964989
-
The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency.
J Virol. 1994 Dec;68(12):8045-55
PMID: 7966594
-
Functional role of type I and type II interferons in antiviral defense.
Science. 1994 Jun 24;264(5167):1918-21
PMID: 8009221
-
The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice.
J Gen Virol. 1994 Aug;75 ( Pt 8):2059-63
PMID: 8046409
-
A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement.
Virology. 1994 Mar;199(2):484-90
PMID: 8122378
-
Mapping the genetic region coding for herpes simplex virus resistance to mouse interferon alpha/beta.
J Gen Virol. 1993 Nov;74 ( Pt 11):2325-32
PMID: 8245849
-
ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures.
J Virol. 1994 Jan;68(1):48-55
PMID: 8254758
-
Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0).
J Gen Virol. 1993 Dec;74 ( Pt 12):2679-90
PMID: 8277273
-
In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts.
J Gen Virol. 1993 Sep;74 ( Pt 9):1859-69
PMID: 8397283
-
The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells.
J Virol. 1996 Jan;70(1):84-90
PMID: 8523596
-
Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
J Virol. 1996 Feb;70(2):1271-6
PMID: 8551594
-
Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled.
J Immunol. 1996 May 15;156(10):3901-10
PMID: 8621929
-
The role of the innate immune system in the reconstituted SCID mouse model of herpetic stromal keratitis.
Clin Immunol Immunopathol. 1996 Jul;80(1):23-30
PMID: 8674236
-
Inhibition of herpes simplex virus type 1 immediate-early gene expression by alpha interferon is not VP16 specific.
J Virol. 1996 Sep;70(9):6336-9
PMID: 8709261
-
Effect of interferon-alpha on the steady-state levels of thymine, thymidine, guanine, and guanosine metabolites in herpes simplex virus-type 1-infected cells.
Intervirology. 1995;38(5):249-55
PMID: 8724854
-
Role of cis-acting sequences of the ICPO promoter of herpes simplex virus type 1 in viral pathogenesis, latency and reactivation.
J Gen Virol. 1996 Aug;77 ( Pt 8):1853-63
PMID: 8760437
-
Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0.
J Virol. 1996 Nov;70(11):7471-7
PMID: 8892865
-
The virion host shutoff function of herpes simplex virus type 1 plays a role in corneal invasion and functions independently of the cell cycle.
Virology. 1997 Apr 28;231(1):28-34
PMID: 9143299
-
The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27.
J Virol. 1997 Jun;71(6):4614-25
PMID: 9151855
-
Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis.
J Virol. 1997 Sep;71(9):6850-62
PMID: 9261410
-
Innate and acquired immunity to herpes simplex virus type 1.
Virology. 1997 Sep 29;236(2):328-37
PMID: 9325240
-
Interferon-gamma protects against herpes simplex virus type 1-mediated neuronal death.
Virology. 1997 Nov 24;238(2):189-97
PMID: 9400592
-
Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response.
J Exp Med. 1998 Feb 2;187(3):341-8
PMID: 9449714
-
The BglII-N fragment of herpes simplex virus type 2 contains a region responsible for resistance to antiviral effects of interferon.
J Gen Virol. 1998 Mar;79 ( Pt 3):565-72
PMID: 9519835
-
The comparative anti-herpes simplex virus effects of human interferons.
J Interferon Cytokine Res. 1998 Mar;18(3):159-65
PMID: 9555977
-
Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting.
Gene Ther. 1998 Apr;5(4):440-50
PMID: 9614567